No Data
No Data
Express News | Nuwellis Announces Publication Of Study In Current Problems in Cardiology Demonstrating The Aquadex Ultrafiltration Therapy Reduced 60 Day Hospital Readmission Rates For ADHF Patients
New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 Days When Using the Aquadex Ultrafiltration Therapy
Nuwellis Secures Funds Through Shares and Warrants Offering
Nuwellis NUWE Offering; Evogene EVGN Direct Offering
Top Midday Decliners
Express News | Nuwellis Shares Are Trading Lower After the Company Announced a $916K Direct Offering of 496,901 Shares at $1.8450 per Share
No Data
No Data